Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines

Young-Mee Kim, Hongryull Pyo

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We investigated whether the combined treatment of 17-(allylamino)-17- demethoxygeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (hsp90), and celecoxib, an inhibitor of cyclooxygenase-2, can cooperatively enhance the radiosensitivity of various human cancer cells. Combined treatment with 17-AAG and celecoxib, at clinically relevant concentrations, cooperatively induced radiosensitization in all tested cancer cells, but not in normal cells. Cooperative radiosensitization by the drug combination was also shown in a human tumor xenograft system. We found that ataxia-telangiectasia and rad3-related (ATR) and ataxia-telangiectasia mutated (ATM) are novel client proteins of hsp90. Combined treatment with 17-AAG and celecoxib cooperatively induced downregulation of ATR and ATM. In conclusion, combined treatment with 17-AAG and celecoxib at clinically relevant concentrations may significantly enhance the therapeutic efficacy of ionizing radiation.

Original languageEnglish (US)
Pages (from-to)15-29
Number of pages15
JournalDNA and cell biology
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Celecoxib
tanespimycin
Ataxia Telangiectasia
Radiation Tolerance
Colonic Neoplasms
Lung Neoplasms
HSP90 Heat-Shock Proteins
Cell Line
Neoplasms
Cyclooxygenase 2 Inhibitors
Drug Combinations
Ionizing Radiation
Heterografts
Down-Regulation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines. / Kim, Young-Mee; Pyo, Hongryull.

In: DNA and cell biology, Vol. 31, No. 1, 01.01.2012, p. 15-29.

Research output: Contribution to journalArticle

@article{2226059d741f4db29e38251ac08564a9,
title = "Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines",
abstract = "We investigated whether the combined treatment of 17-(allylamino)-17- demethoxygeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (hsp90), and celecoxib, an inhibitor of cyclooxygenase-2, can cooperatively enhance the radiosensitivity of various human cancer cells. Combined treatment with 17-AAG and celecoxib, at clinically relevant concentrations, cooperatively induced radiosensitization in all tested cancer cells, but not in normal cells. Cooperative radiosensitization by the drug combination was also shown in a human tumor xenograft system. We found that ataxia-telangiectasia and rad3-related (ATR) and ataxia-telangiectasia mutated (ATM) are novel client proteins of hsp90. Combined treatment with 17-AAG and celecoxib cooperatively induced downregulation of ATR and ATM. In conclusion, combined treatment with 17-AAG and celecoxib at clinically relevant concentrations may significantly enhance the therapeutic efficacy of ionizing radiation.",
author = "Young-Mee Kim and Hongryull Pyo",
year = "2012",
month = "1",
day = "1",
doi = "10.1089/dna.2011.1342",
language = "English (US)",
volume = "31",
pages = "15--29",
journal = "DNA and Cell Biology",
issn = "1044-5498",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Cooperative enhancement of radiosensitivity after combined treatment of 17-(allylamino)-17-demethoxygeldanamycin and celecoxib in human lung and colon cancer cell lines

AU - Kim, Young-Mee

AU - Pyo, Hongryull

PY - 2012/1/1

Y1 - 2012/1/1

N2 - We investigated whether the combined treatment of 17-(allylamino)-17- demethoxygeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (hsp90), and celecoxib, an inhibitor of cyclooxygenase-2, can cooperatively enhance the radiosensitivity of various human cancer cells. Combined treatment with 17-AAG and celecoxib, at clinically relevant concentrations, cooperatively induced radiosensitization in all tested cancer cells, but not in normal cells. Cooperative radiosensitization by the drug combination was also shown in a human tumor xenograft system. We found that ataxia-telangiectasia and rad3-related (ATR) and ataxia-telangiectasia mutated (ATM) are novel client proteins of hsp90. Combined treatment with 17-AAG and celecoxib cooperatively induced downregulation of ATR and ATM. In conclusion, combined treatment with 17-AAG and celecoxib at clinically relevant concentrations may significantly enhance the therapeutic efficacy of ionizing radiation.

AB - We investigated whether the combined treatment of 17-(allylamino)-17- demethoxygeldanamycin (17-AAG), an inhibitor of heat-shock protein 90 (hsp90), and celecoxib, an inhibitor of cyclooxygenase-2, can cooperatively enhance the radiosensitivity of various human cancer cells. Combined treatment with 17-AAG and celecoxib, at clinically relevant concentrations, cooperatively induced radiosensitization in all tested cancer cells, but not in normal cells. Cooperative radiosensitization by the drug combination was also shown in a human tumor xenograft system. We found that ataxia-telangiectasia and rad3-related (ATR) and ataxia-telangiectasia mutated (ATM) are novel client proteins of hsp90. Combined treatment with 17-AAG and celecoxib cooperatively induced downregulation of ATR and ATM. In conclusion, combined treatment with 17-AAG and celecoxib at clinically relevant concentrations may significantly enhance the therapeutic efficacy of ionizing radiation.

UR - http://www.scopus.com/inward/record.url?scp=84855450333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855450333&partnerID=8YFLogxK

U2 - 10.1089/dna.2011.1342

DO - 10.1089/dna.2011.1342

M3 - Article

VL - 31

SP - 15

EP - 29

JO - DNA and Cell Biology

JF - DNA and Cell Biology

SN - 1044-5498

IS - 1

ER -